000 01761 a2200457 4500
005 20250515041834.0
264 0 _c20061207
008 200612s 0 0 eng d
022 _a1535-7163
024 7 _a10.1158/1535-7163.MCT-05-0480
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHrzenjak, Andelko
245 0 0 _aValproate inhibition of histone deacetylase 2 affects differentiation and decreases proliferation of endometrial stromal sarcoma cells.
_h[electronic resource]
260 _bMolecular cancer therapeutics
_cSep 2006
300 _a2203-10 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCell Differentiation
_xdrug effects
650 0 4 _aCell Growth Processes
_xdrug effects
650 0 4 _aCyclin-Dependent Kinase Inhibitor p21
_xbiosynthesis
650 0 4 _aEndometrial Neoplasms
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHistone Deacetylase 1
650 0 4 _aHistone Deacetylase 2
650 0 4 _aHistone Deacetylase Inhibitors
650 0 4 _aHistone Deacetylases
_xbiosynthesis
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aRNA, Small Interfering
_xgenetics
650 0 4 _aRepressor Proteins
_xantagonists & inhibitors
650 0 4 _aSarcoma, Endometrial Stromal
_xdrug therapy
650 0 4 _aTumor Cells, Cultured
650 0 4 _aValproic Acid
_xpharmacology
700 1 _aMoinfar, Farid
700 1 _aKremser, Marie-Luise
700 1 _aStrohmeier, Bettina
700 1 _aStaber, Philipp B
700 1 _aZatloukal, Kurt
700 1 _aDenk, Helmut
773 0 _tMolecular cancer therapeutics
_gvol. 5
_gno. 9
_gp. 2203-10
856 4 0 _uhttps://doi.org/10.1158/1535-7163.MCT-05-0480
_zAvailable from publisher's website
999 _c16563861
_d16563861